Published in J Biol Chem on April 14, 2015
A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet (2016) 0.85
MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR. Int J Clin Exp Pathol (2015) 0.81
miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer. Sci Rep (2016) 0.80
MicroRNA-182 prevents vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ signaling. Int J Mol Med (2017) 0.75
Emerging Role of MicroRNAs in mTOR Signaling. Cell Mol Life Sci (2017) 0.75
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit. Mol Cancer (2017) 0.75
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget (2016) 0.75
Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways. Oncotarget (2017) 0.75
Bioinformatic Studies to Predict MicroRNAs with the Potential of Uncoupling RECK Expression from Epithelial-Mesenchymal Transition in Cancer Cells. Cancer Inform (2016) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
Human MicroRNA targets. PLoS Biol (2004) 34.51
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology (1991) 30.87
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51
rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res (2004) 4.93
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol (2010) 3.27
Sin3: a flexible regulator of global gene expression and genome stability. Curr Genet (2004) 2.60
MicroRNA gene expression in the mouse inner ear. Brain Res (2006) 2.13
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol (2010) 1.74
MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology (2012) 1.64
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res (2011) 1.49
Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res (2011) 1.48
The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol (2010) 1.44
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation. J Exp Med (2009) 1.39
Efficient in vivo microRNA targeting of liver metastasis. Oncogene (2010) 1.36
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One (2013) 1.27
MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS One (2012) 1.27
Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology (1998) 1.25
Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis (2003) 1.23
Signal transduction via the growth hormone receptor. Cell Signal (2001) 1.22
Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. Biochem Biophys Res Commun (2004) 1.18
Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res (2005) 1.14
Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci U S A (2004) 1.13
Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia (2012) 1.11
High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol (2002) 1.05
The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia (2010) 1.02
Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma. J Clin Endocrinol Metab (2011) 1.01
Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res (2012) 1.01
DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene (2007) 0.98
The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology (2001) 0.98
Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol (2011) 0.96
Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior. Endocrinology (2009) 0.96
Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia (1997) 0.96
Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res (1999) 0.95
Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression. FEBS Lett (2011) 0.93
BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. Nat Commun (2014) 0.93
Stat5 in the mammary gland: controlling normal development and cancer. J Cell Physiol (2006) 0.92
Growth hormone as a cytokine. Clin Exp Pharmacol Physiol (1999) 0.91
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Endocrinology (2008) 0.90
The contribution of growth hormone to mammary neoplasia. J Mammary Gland Biol Neoplasia (2008) 0.90
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol Diagn Ther (2012) 0.88
AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone. J Biol Chem (2006) 0.88
Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. J Biol Chem (2001) 0.86
STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. Endocrinology (2010) 0.85
Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem (1996) 0.83
Growth hormone and cancer: an update on progress. Curr Opin Endocrinol Diabetes Obes (2013) 0.79
RNA interference-mediated silencing of Stat5 induces apoptosis and growth suppression of hepatocellular carcinoma cells. Neoplasma (2012) 0.79
Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis. Mol Carcinog (2014) 0.77